Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 26 to 50 of 757

TitleReference numberPublishedLast updated
Aflibercept solution for injection for treating wet age‑related macular degenerationTA294
Agomelatine for the treatment of major depressive episodes (terminated appraisal)TA231
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)TA438
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosisTA312
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemiaTA393
Alitretinoin for the treatment of severe chronic hand eczemaTA177
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
Alteplase for treating acute ischaemic strokeTA264
Amantadine, oseltamivir and zanamivir for the treatment of influenzaTA168
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
Anakinra for treating Still's diseaseTA685
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancerTA740
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancerTA741
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA275
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adultsTA245
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Apremilast for treating active psoriatic arthritisTA433
Apremilast for treating moderate to severe plaque psoriasisTA419
Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 yearsTA213
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorderTA292
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526

Results per page

  1. 10
  2. 25
  3. 50
  4. All